Company Filing History:
Years Active: 1998-2005
Title: Innovations of David John Bull
Introduction
David John Bull is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address thrombotic conditions. With a total of 5 patents to his name, Bull's work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents are the 3-(imidazolyl)-2-alkoxypropanoic acids. These compounds are characterized by a specific formula where n ranges from 0 to 3. The compounds feature R groups that can be optionally substituted C alkyl, C alkenyl, or C alkynyl, as well as heterocycles, aromatic heterocycles, aryl groups, or hydrogen. The unique structure of these compounds makes them novel and useful in treating thrombotic conditions and other pathologies associated with fibrin deposition.
Career Highlights
David John Bull is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions in drug development. His contributions have been instrumental in advancing therapeutic options for patients suffering from various medical conditions.
Collaborations
Throughout his career, Bull has collaborated with several esteemed colleagues, including Robert John Maguire and Charlotte Moira Norfor Allerton. These collaborations have fostered a productive environment for innovation and research.
Conclusion
David John Bull's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.